Health ❯ Chronic Conditions

Obesity

Treatment Options Diabetes Weight Management Type 2 Diabetes Hypertension Inflammation Health Risks Weight Loss Medications Comorbidities Weight Loss Drugs Weight Loss Insulin Resistance Medication Weight Regain Infectious Diseases Circadian Health Heart Disease Health Outcomes Management of Obesity Weight Loss Supplements Medical Outcomes Heart Health Clinical Guidelines Elderly Care Medication Risks Cardiovascular Health Treatment Plans High Cholesterol Treatment Guidelines Dietary Impact Metabolic Syndrome Multidisciplinary Care Metabolic Factors Management Strategies Stroke Medication Management Treatment Approaches BMI Nutritional Deficiencies Diabetes Type 2 Related Health Issues Cardiometabolic Health Weight Loss Strategies Dietary Restrictions BMI Classification Management Clinical Obesity Body Mass Index Drug Side Effects BMI Categories Diabetes Management Cardiovascular Diseases Impact on Sleep Statistics

Shaquille O’Neal Says Zepbound Has Eased His Obstructive Sleep Apnea

His public campaign with Eli Lilly draws attention to an FDA-approved drug option for obesity-linked sleep apnea.

Lilly’s GLP‑1 Sales and PBM Coverage Fuel Record Quarter as Pipeline Logs Durable Wins

PCOS Is Officially Renamed PMOS After Global Consensus

Study Links Longer, Frequent, Morning Naps to Higher Death Risk in Older Adults

GLP-1 Weight-Loss Draws Harsher Stigma Than Lifestyle Change, Study Finds

New Analyses Link GLP-1 Drugs to Modest Bone and Gout Risks, With Mixed Patterns by Diabetes Status

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

JAMA Forecast: Nearly Half of U.S. Adults Could Have Obesity by 2035

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

Six Midlife Depressive Symptoms Tied to Higher Dementia Risk Decades Later

Florida Supreme Court Lets Frank Walls’ Execution Proceed as Federal Appeal Targets Lethal-Injection Practices

Lilly's Rally Deepens as U.S. Access Deal Recasts Outlook for GLP‑1 Drugs

White House Clinches GLP-1 Price Deal as Lilly Sets Zepbound and Pill Pricing

AHA Survey Finds Most Americans Unaware of CKM Syndrome That Puts Nearly All at Risk

Study Finds 1 in 7 Pregnancies Involve Cardiovascular Complications

Danish Study: Underweight and Severe Obesity Carry Highest Death Risk in U-Shaped BMI Pattern

Stanford Study Finds Permanent Standard Time Would Deliver Biggest Health Gains

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

CDC Study Finds Most U.S. Women Carry Modifiable Risks for Birth Defects